CAV1 and psoriasis: Silencing of Cav-1 in keratinocytes in vitro caused an increased expression of different cytokines/chemokines, such as IL-6, CXCL8, and CXCL9, whereas the application of a Cav-1 scaffolding domain peptide in a murine skin model of psoriasis effectively reduces their expression [58].